<DOC>
<DOCNO>
EP-0004639
</DOCNO>
<TEXT>
<DATE>
19791017
</DATE>
<IPC-CLASSIFICATIONS>
C07H-19/00 <main>C07H-19/20</main> C12Q-1/00 A61K-47/42 C07H-19/207 
</IPC-CLASSIFICATIONS>
<TITLE>
stabilized nicotinamide-adenine-dinucleotides, process for their preparation and use of a stabilizator.
</TITLE>
<APPLICANT>
behringwerke agde<sep>behringwerke aktiengesellschaft<sep>behringwerke aktiengesellschaftpostfach 114035001 marburgde<sep>behringwerke aktiengesellschaft<sep>
</APPLICANT>
<INVENTOR>
muller-matthesius reinhard dr<sep>stark joseph dr<sep>muller-matthesius, reinhard, dr.<sep>stark, joseph, dr.<sep>m체ller-matthesius, reinhard, dr.am weinberg 6cd-3550 marburg/lahnde<sep>st채rk, joseph, dr.geschwister-scholl-strasse 23d-3550 marburg/lahnde<sep>muller-matthesius, reinhard, dr.<sep>stark, joseph, dr. <sep>m체ller-matthesius, reinhard, dr. am weinberg 6c d-3550 marburg/lahnde<sep>st채rk, joseph, dr.geschwister-scholl-strasse 23d-3550 marburg/lahnde<sep>
</INVENTOR>
<ABSTRACT>
Nicotinamide adenin dinucleotide or its phosphate, each in both reduced and oxidized form, is stabilized against efficacy losses during storage by the addition of hydrolytically degraded, optionally cross-linked collagen.
</ABSTRACT>
</TEXT>
</DOC>
